Please note
This trial is no longer recruiting patients. We hope to add results when they are available.
Breast cancer
Closed
Phase 2
This trial is comparing letrozole and megestrol acetate with letrozole on its own before surgery to remove breast cancer. It is for women who:
can no longer become pregnant (
have breast cancer that is sensitive to the female hormone oestrogen ( or ER positive)
Recruitment start: 20 July 2017
Recruitment end: 31 October 2022
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Richard Baird
Anticancer Fund
Cambridge University Hospitals NHS Foundation Trust
Cancer Research UK Cambridge Centre
University of Cambridge
National Institute for Health Research
Last reviewed: 13 August 2024
CRUK internal database number: 15022